In regulated healthcare markets, leaving regulatory planning too late, or treating it as a separate technical workstream, has serious commercial consequences. It affects your fundraising timeline, your development roadmap, your partnership conversations, and your credibility with investors who have seen regulatory processes derail good companies before.
The companies that navigate this well are the ones that integrate regulatory thinking into their strategic planning from the beginning. They understand which pathway fits their evidence base, what the timeline and cost implications are, and how to communicate that pathway clearly to the people who need to believe in it.
We have achieved CE marking for AI-driven oncology biomarkers and FDA clearance for an imaging platform. We have managed the cross-functional teams and clinical evidence packages required to get there. We bring that experience to your regulatory planning, connected to your wider commercial strategy and not separated from it.
Mapping the CE marking or FDA clearance route for your product, including pre-submission strategy, evidence requirements, and timeline planning aligned with your commercial objectives.
Preparing the technical documentation, clinical evidence package, and quality management frameworks required for CE marking under MDR and IVDR.
Advising on 510(k), De Novo, or PMA pathways, pre-submission meetings, and the clinical and technical evidence required to support your submission.
Ensuring that regulatory planning is integrated with your product development roadmap, fundraising milestones, and go-to-market timing, not treated as a separate problem.
Designing clinical and analytical validation strategies that satisfy regulatory requirements while generating commercially useful data.
Translating your regulatory pathway into clear, credible language for investor decks, data rooms, and due diligence conversations.
GoldWhite provides strategic regulatory advisory and planning. Where formal specialist regulatory, legal, or notified-body services are required, we work alongside or prepare companies for engagement with the appropriate external experts.
Regulatory strategy engagements are typically scoped as defined projects covering pathway planning, evidence strategy, and investor communication packages, or integrated into ongoing retained advisory where regulatory progress is part of a wider growth programme.